ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,194Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 113

$770K Total Retail Price of All Prescriptions

Rank: 4 out of 113

563 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 563 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 563 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 10,776 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
SIMVASTATIN 800 705 1 2
LEVOTHYROXINE SODIUM 567 533 2 1
FUROSEMIDE 388 349 3 6
HYDROCHLOROTHIAZIDE 345 323 4 9
WARFARIN SODIUM 320 280 5 8
METOPROLOL TARTRATE 298 264 6 14
OMEPRAZOLE 277 242 7 5
ALLOPURINOL 260 235 8 20
LISINOPRIL 251 222 9 3
ENALAPRIL MALEATE 219 204 10 50
ZOLPIDEM TARTRATE 204 180 11 19
HYDROCODONE-ACETAMINOPHEN 193 174 S3 12 7
METFORMIN HCL 191 176 13 11
CITALOPRAM HBR 181 144 14 17
TRAMADOL HCL 179 152 15 29
POTASSIUM CHLORIDE 177 152 16 12
AMLODIPINE BESYLATE 171 164 17 4
METOPROLOL SUCCINATE 162 151 18 10
KLOR-CON M20 160 150 19 60
SPIRIVA 136 124 20 54
GABAPENTIN 133 103 21 18
ATENOLOL 123 116 22 16
SERTRALINE HCL 119 104 23 21
DOXAZOSIN MESYLATE 112 111 24 49
ADVAIR DISKUS 111 101 25 35
ALENDRONATE SODIUM 110 92 26 22
TAMSULOSIN HCL 109 91 27 24
LOSARTAN-HYDROCHLOROTHIAZIDE 109 101 27 40
FLUOXETINE HCL 107 78 29 31
DIGOXIN 97 94 30 27
PREDNISONE 96 94 31 28
ATORVASTATIN CALCIUM 94 93 32 15
ENALAPRIL-HYDROCHLOROTHIAZIDE 94 84 32 162
TRAZODONE HCL 93 54 34 41
GLIPIZIDE ER 91 66 35 97
QUETIAPINE FUMARATE 87 80 36 83
FLUTICASONE PROPIONATE 85 80 37 39
LOSARTAN POTASSIUM 84 84 38 13
PANTOPRAZOLE SODIUM 83 73 39 52
MELOXICAM 78 71 40 44
CARVEDILOL 76 62 41 25
LANTUS 71 56 42 38
CRESTOR 70 68 43 30
PROPRANOLOL HCL 68 47 44 92
CIPROFLOXACIN HCL 65 60 45 63
NAMENDA 63 59 46 48
ROPINIROLE HCL 63 52 46 67
METHYLPREDNISOLONE 62 58 48 147
BUPROPION XL 61 60 49 101
CLOPIDOGREL 60 51 50 56
FENTANYL 60 60 S2 50 43
NIFEDIPINE ER 59 55 52 132
PRADAXA 58 52 53 151
COLCRYS 58 58 53 187
CYMBALTA 58 57 53 37
VENLAFAXINE HCL ER 57 53 56 55
NEXIUM 57 42 56 47
ISOSORBIDE MONONITRATE ER 55 52 58 82
FINASTERIDE 53 47 59 87
CELEBREX 52 46 60 90
OXYBUTYNIN CHLORIDE ER 51 51 61 112
PRAVASTATIN SODIUM 51 51 61 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.